Parameswaran Hari


Ontology type: schema:Person     


Person Info

NAME

Parameswaran

SURNAME

Hari

Publications in SciGraph latest 50 shown

  • 2018-12 Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation in BMC CANCER
  • 2018-09 Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective in BONE MARROW TRANSPLANTATION
  • 2018-09 Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1 in LEUKEMIA
  • 2018-06-15 Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival in BONE MARROW TRANSPLANTATION
  • 2018-04 Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time in LEUKEMIA
  • 2018 Haploidentical Hematopoietic Cell Transplantation in Lymphomas in HAPLOIDENTICAL TRANSPLANTATION
  • 2017-12 Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis in BONE MARROW TRANSPLANTATION
  • 2017-12 Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes in LEUKEMIA
  • 2017-09 Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004–2014 in LEUKEMIA
  • 2017-01 Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft in BONE MARROW TRANSPLANTATION
  • 2017-01 A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2016-12 Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD? in BONE MARROW TRANSPLANTATION
  • 2016-12 Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections in BONE MARROW TRANSPLANTATION
  • 2016-11 HLA polymorphism and risk of multiple myeloma in LEUKEMIA
  • 2016-04 Allogeneic stem cell transplantation for multiple myeloma: is there a future? in BONE MARROW TRANSPLANTATION
  • 2016-04 Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms in BONE MARROW TRANSPLANTATION
  • 2016-02 Monocyte recovery at day 100 is associated with improved survival in multiple myeloma patients who undergo allogeneic hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2016-01 Minimal residual disease testing after stem cell transplantation for multiple myeloma in BONE MARROW TRANSPLANTATION
  • 2016-01 Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma in BONE MARROW TRANSPLANTATION
  • 2015-12 Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2015-07 Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma in BONE MARROW TRANSPLANTATION
  • 2015-07 Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation in BONE MARROW TRANSPLANTATION
  • 2015-04 Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis in BONE MARROW TRANSPLANTATION
  • 2015-03 Chronic GVHD and concurrent new-onset nephrotic syndrome in allogeneic transplant recipients. Incidence, pattern and therapeutic outcomes in BONE MARROW TRANSPLANTATION
  • 2014-11 Clinical and imaging predictors of 1-year and long-term mortality in light chain (AL) amyloidosis: a 5-year follow-up study in HEART AND VESSELS
  • 2014-11 Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome in BONE MARROW TRANSPLANTATION
  • 2014-06 Incidence and outcomes of Clostridium difficile-associated disease in hematopoietic cell transplant recipients in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2014-03 Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation in BONE MARROW TRANSPLANTATION
  • 2013-11 Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era? in BONE MARROW TRANSPLANTATION
  • 2012-06 Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma in BONE MARROW TRANSPLANTATION
  • 2012-05 Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research in LEUKEMIA
  • 2012-03 High prevalence of Dapsone-induced oxidant hemolysis in North American SCT recipients without glucose-6-phosphate-dehydrogenase deficiency in BONE MARROW TRANSPLANTATION
  • 2011-12 Percussion hemoglobinuria - a novel term for hand trauma-induced mechanical hemolysis: a case report in JOURNAL OF MEDICAL CASE REPORTS
  • 2010-07 Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study in LEUKEMIA
  • 2009-12 Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up in BMC MEDICAL PHYSICS
  • 2009-08 Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant in LEUKEMIA
  • 2009-01 Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma in BONE MARROW TRANSPLANTATION
  • 2008-12 Intraventricular dyssynchrony in light chain amyloidosis: a new mechanism of systolic dysfunction assessed by 3-dimensional echocardiography in CARDIOVASCULAR ULTRASOUND
  • 2008-10 223 Adverse functional significance of delayed enhancement on cardiac MRI in primary systemic amyloidosis in JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE
  • 2007-02 Suppressive Anti-HCV Therapy for Prevention of Donor to Recipient Transmission in Stem Cell Transplantation in THE AMERICAN JOURNAL OF GASTROENTEROLOGY
  • 2006-01 Cure of multiple myeloma – more hype, less reality in BONE MARROW TRANSPLANTATION
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.30760.32", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415792.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.268154.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415100.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410425.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5288.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.468189.a", 
            "type": "Organization"
          }
        ], 
        "familyName": "Hari", 
        "givenName": "Parameswaran", 
        "id": "sg:person.01170403141.13", 
        "identifier": {
          "name": "orcid_id", 
          "type": "PropertyValue", 
          "value": [
            "0000-0002-8800-297X"
          ]
        }, 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170403141.13", 
          "https://orcid.org/0000-0002-8800-297X"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:47", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_518.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01170403141.13'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01170403141.13'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01170403141.13'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01170403141.13'


     

    This table displays all metadata directly associated to this object as RDF triples.

    33 TRIPLES      11 PREDICATES      19 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01170403141.13 schema:affiliation N49b1e1965398455488a4a2d436de823c
    2 https://www.grid.ac/institutes/grid.268154.c
    3 https://www.grid.ac/institutes/grid.410425.6
    4 https://www.grid.ac/institutes/grid.415100.1
    5 https://www.grid.ac/institutes/grid.415792.c
    6 https://www.grid.ac/institutes/grid.468189.a
    7 https://www.grid.ac/institutes/grid.5288.7
    8 schema:familyName Hari
    9 schema:givenName Parameswaran
    10 schema:identifier N586f9aa417bb439caa8ed57c85115e89
    11 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170403141.13
    12 https://orcid.org/0000-0002-8800-297X
    13 schema:sdDatePublished 2019-03-07T14:47
    14 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    15 schema:sdPublisher Na9c170731c614424810dd8098e5698b4
    16 sgo:license sg:explorer/license/
    17 sgo:sdDataset persons
    18 rdf:type schema:Person
    19 N49b1e1965398455488a4a2d436de823c schema:affiliation https://www.grid.ac/institutes/grid.30760.32
    20 sgo:isCurrent true
    21 rdf:type schema:OrganizationRole
    22 N586f9aa417bb439caa8ed57c85115e89 schema:name orcid_id
    23 schema:value 0000-0002-8800-297X
    24 rdf:type schema:PropertyValue
    25 Na9c170731c614424810dd8098e5698b4 schema:name Springer Nature - SN SciGraph project
    26 rdf:type schema:Organization
    27 https://www.grid.ac/institutes/grid.268154.c schema:Organization
    28 https://www.grid.ac/institutes/grid.30760.32 schema:Organization
    29 https://www.grid.ac/institutes/grid.410425.6 schema:Organization
    30 https://www.grid.ac/institutes/grid.415100.1 schema:Organization
    31 https://www.grid.ac/institutes/grid.415792.c schema:Organization
    32 https://www.grid.ac/institutes/grid.468189.a schema:Organization
    33 https://www.grid.ac/institutes/grid.5288.7 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...